Drug repurposing for progressive multiple sclerosis

Update: 2021-03-02

Description

Prof Alaisdair Coles and Dr Nick Cunniffe, The University of Cambridge joins editor Colin Mahoney to discuss:

The work carried out by a team of researchers alongside the MS Society in the United Kingdom. The authors discuss the process of identifying therapies to repurpose in future MS trials and why they think this drugs may work. https://jnnp.bmj.com/content/92/3/295

Comments

In Channel

CGRP in migraine: current therapeutics, future implications and potential off-target effects

2021-12-2110:01

Localisation in focal epilepsies

2021-12-0344:40

Alemtuzumab's impact on functional and structural integrity of the visual system in MS

2021-11-1720:02

Editors Highlights of the December 2021 issue

2021-11-1235:32

Autoimmune encephalitis: clinical spectrum and management

2021-10-1130:38

Guidelines for the management of functional speech and communication disorders

2021-09-2723:09

Editors Highlights of the October 2021 issue

2021-09-1031:05

The impact of traumatic brain injury on neurocognitive outcomes in children

2021-08-3109:54

Suspecting dementia: canaries, chameleons and zebras

2021-08-0629:15

Editors Highlights of the August 2021 issue

2021-07-0630:18

Cerebral Microbleeds: from depiction to interpretation

2021-07-0510:23

Motor functional neurological disease, a decade of progress

2021-06-2509:52

COVID - 19 Vaccination and risk of large vessel arterial stroke

2021-06-0313:15

Editors Highlights of the June 2021 issue

2021-05-2028:24

Editors Highlights of the April 2021 issue

2021-04-1426:08

Drug repurposing for progressive multiple sclerosis

2021-03-0208:48

Editors Highlights of the February 2021 issue

2021-02-2122:14

Peripheral nerve blocks for headache disorders

2021-01-2116:07

Editors Highlights of the December 2020 issue

2020-12-0921:11

Isaacs syndrome the crossroads of Neurology, Psychiatry and Immunology

2020-11-2511:56

00:00

Drug repurposing for progressive multiple sclerosis

#box-pro-ellipsis-176138878978880{-webkit-line-clamp:2;}Drug repurposing for progressive multiple sclerosis

Drug repurposing for progressive multiple sclerosis

BMJ talk medicine

Drug repurposing for progressive multiple sclerosis